Iodine: Far More Than a Thyroid Mineral
The relationship between iodine and the thyroid is well established. Iodine is essential for the production of thyroid hormones — the numbers in T3 and T4 refer to the number of iodine molecules attached to the amino acid tyrosine. But iodine's role in the body extends far beyond the thyroid gland.
Iodine is present in every organ and tissue of the human body, and in a state of adequate iodine sufficiency, approximately 50 to 70% of total body iodine is distributed to extrathyroidal tissues. These include the breasts, ovaries, uterus, placenta, prostate, thymus, salivary glands, lacrimal glands, eyes, skin, gastric mucosa, adrenal cortex, pancreas, liver, and intestinal mucosa.
This article explores the critical roles that iodine plays in breast health, ovarian function, fertility, endometrial health, and fetal brain development — and explains why thyroid blood tests alone are insufficient to assess whole-body iodine status.
How the Thyroid Uses Iodine
Thyroid hormone production begins in the follicular cells of the thyroid gland. Iodide is actively transported into these cells via the sodium-iodide symporter (NIS) protein. The thyroid synthesises thyroglobulin, which contains approximately 140 tyrosine residues. Iodide enters the follicular lumen via the pendrin transporter, where it is oxidised to iodine by the enzyme thyroid peroxidase (TPO). TPO then links iodine to tyrosine residues to form T1 and T2. Two T2 molecules combine to form T4, while T1 and T2 combine to form T3. Thyroid hormones are released into circulation at a ratio of approximately 4:1 (T4 to T3).
T4 is converted to the more active T3 in peripheral tissues — primarily the liver, kidneys, and muscles — by deiodinase enzymes. This conversion releases one iodine molecule, which can be salvaged and redistributed within the body. If peripheral T4-to-T3 conversion is impaired, less iodine becomes available to extrathyroidal tissues.
Why Thyroid Markers Cannot Assess Whole-Body Iodine Status
The thyroid and extrathyroidal tissues both use iodide transporters to regulate intracellular iodine concentrations. When tissue iodine is low, transporter expression increases to capture more dietary iodine. Critically, the thyroid receives a disproportionately high share of available iodine under conditions of deficiency — meaning thyroid hormone levels may remain within the normal range even when extrathyroidal tissues are significantly depleted.
The current Recommended Dietary Allowance (RDA) of 150 mcg per day was established with the singular goal of preventing goitre. At this intake level, extrathyroidal tissues may remain iodine-deficient even when thyroid function appears normal. This is why urinary iodine testing — not thyroid blood tests — is the most accurate method for assessing whole-body iodine status.
The Iodine and Creatinine Urine Spot Test Kit measures urinary iodide concentration alongside creatinine for accurate, normalised assessment of iodine status from a simple home-collected dried urine sample.
Iodine and Breast Health
Breast tissue is one of the most iodine-active extrathyroidal sites in the body. During lactation, the mammary glands concentrate iodine and secrete it into breast milk to supply this essential nutrient to the newborn. Outside of lactation, iodine plays a protective role in breast tissue health.
Iodine Deficiency and Fibrocystic Breast Disease
Iodine deficiency has been associated with fibrocystic breast disease — a common benign condition characterised by lumpy, tender breast tissue. The hormonal environment that promotes fibrocystic changes may also increase the risk of breast cancer in some women. Research has shown that iodine deficiency can cause hyperresponsiveness to oestradiol, which increases alveolar cell proliferation in breast tissue.
Iodine and Breast Cancer Risk
The reemergence of iodine deficiency in Western populations since the 1970s has been associated with an increasing incidence of distant metastatic breast cancer in younger women aged 25 to 39. Molecular iodine (I₂) has been shown to suppress breast cancer cell and tumour growth. Research published in the Journal of Clinical Endocrinology and Metabolism demonstrated that molecular iodine administered alongside a carcinogen significantly reduced the incidence and size of mammary tumours in animal models.
Iodine may also improve oestrogen metabolism by directing oestradiol down the 2-hydroxyestradiol pathway via cytochrome P450 enzyme activity. This metabolic pathway has antiproliferative effects, potentially reducing the risk of oestrogen-driven breast tissue changes.
Iodine and Ovarian Function
Of all the tissues that utilise iodine, the ovaries have one of the highest concentrations in the body. Iodine is an essential micronutrient for normal reproductive function, and deficiency is associated with reduced fertility.
Iodine Deficiency and Fertility
A large observational study conducted by the National Institute of Child Health and Human Development followed 467 women trying to conceive between 2005 and 2009. The study found that 44.3% of participants were iodine-deficient, as determined by a urinary iodide concentration below 50 mcg/g. Women with low iodine were 46% less likely to achieve pregnancy during each menstrual cycle compared to women with normal iodine levels.
Iodine appears to be necessary for the process of ovulation itself. Small and growing follicles take up iodine to support secretory activity. In animal studies, artificially induced iodine deficiency in cows resulted in anovulatory cycles — cycles in which ovulation did not occur.
Iodine Deficiency and PCOS
Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders in women of reproductive age, characterised by anovulatory cycles and the formation of ovarian cysts. Iodine deficiency negatively impacts folliculogenesis — the maturation of ovarian follicles. When a follicle fails to mature, ovulation cannot occur, and the immature follicle may evolve into a fluid-filled cyst within the ovary.
Continuous stimulation of immature follicles by luteinising hormone (LH) may also increase androgen production, contributing to the hormonal profile characteristic of PCOS. Addressing iodine deficiency may therefore be an important nutritional consideration in the management of PCOS and anovulatory infertility.
For women investigating hormonal causes of irregular cycles, PCOS, or fertility challenges, the Thyroid and Iodine Test Kit assesses both thyroid function and iodine status together — providing a comprehensive picture of two closely linked systems that influence ovarian health and reproductive outcomes.
Iodine and Endometrial Health
Iodine also plays a role in endometrial health and pregnancy outcomes. A 2020 study by Bilal et al. evaluated iodide transporter levels in the endometrial tissue of women with recurrent reproductive failures. Compared to controls, women with two or more pregnancy losses had a greater than fivefold increase in NIS and pendrin iodide transporters — suggesting abnormal iodine metabolism and localised iodine deficiency in the endometrium.
During pregnancy, demand for T4 increases significantly, as the fetus relies on maternal thyroid hormones during the first trimester before its own thyroid becomes functional. Reduced thyroid hormone availability during this critical window can result in fetal neurological damage, congenital hypothyroidism, miscarriage, and recurrent pregnancy failure. Beyond thyroid hormones, iodide and molecular iodine may also play a direct role in optimising reproductive organ function and pregnancy outcomes by preventing localised iodine deficiency in reproductive tissues.
Iodine and Fetal Brain Development
Iodine is essential for normal brain and nervous system myelination, both in utero and during the early postpartum period. Iodine deficiency remains the most common cause of preventable intellectual disability worldwide. The most vulnerable groups are pregnant and lactating women and their developing fetuses and newborns.
The Critical Window for Iodine in Pregnancy
Adequate iodine intake during the first few weeks of gestation is essential for neurocognitive development in the growing fetus. Iodine supplementation should ideally begin during preconception and no later than four to six weeks of gestation.
Despite this, data from the US National Health and Nutrition Examination Survey (NHANES) indicate that iodine status among pregnant women is frequently insufficient. Although approximately 75% of pregnant women took a prenatal supplement in 2011 to 2014, only 18% of those supplements contained iodine.
Evidence for Iodine Supplementation in Pregnancy
Two prospective studies of iodine supplementation found that infants born to mothers who received iodine during pregnancy had improved psychological and neurocognitive outcomes compared to those born to mothers who did not supplement. A meta-analysis of 37 studies involving 12,291 children demonstrated that children of mothers living in severely iodine-deficient areas had an average of 12.45 fewer IQ points, whereas children born to mothers who supplemented with iodine before and during pregnancy experienced an average increase of 8.7 IQ points.
Iodide vs Molecular Iodine: Understanding the Difference
Not all forms of iodine behave the same way in the body. Understanding the distinction between iodide (I⁻) and molecular iodine (I₂) is important for appreciating how iodine supports different tissues.
Iodide (I⁻) is the primary form used by the thyroid gland to produce thyroid hormones. Its uptake is dependent on active transporter systems — the NIS and pendrin proteins — which act as gatekeepers regulating intracellular iodide concentrations.
Molecular iodine (I₂) is preferentially utilised by extrathyroidal tissues, where it functions as an antioxidant, anti-inflammatory agent, inducer of apoptosis (programmed cell death), immune modulator, and promoter of cell differentiation. The uptake of molecular iodine appears to occur through a facilitated diffusion system, independent of the transporter-based mechanisms used by iodide.
Under conditions of iodine deficiency, iodide is more efficient than molecular iodine at restoring goitrous thyroid function. However, dose-response studies in humans have demonstrated that molecular iodine at concentrations of 1 to 6 mg per day produced significant beneficial effects on fibrocystic breast disease, benign prostatic hyperplasia, and polycystic ovaries.
Iodine Dosing: What the Evidence Suggests
Recommendations for daily iodine intake are a subject of ongoing debate, with suggested doses ranging from 150 mcg per day (the current RDA) to 100 mg per day in some functional medicine protocols. High-dose iodine supplementation carries risks, including the potential to unmask latent thyroid disease, and should only be undertaken under medical supervision.
Based on an assessment of iodine consumption through dietary sources in Japan — a population with historically high iodine intake and low rates of thyroid disease and breast cancer — a more moderate intake of 1 to 3 mg per day has been proposed as a reasonable target to support both thyroid function and the needs of extrathyroidal tissues.
A supplement containing both iodide and molecular iodine may offer the benefit of supporting thyroid function via iodide while simultaneously supporting extrathyroidal tissues via molecular iodine. Ensuring adequate intake of cofactors required for iodine utilisation and thyroid hormone synthesis — including selenium, iron, zinc, copper, magnesium, and vitamin A — is also important for optimising iodine's effects and minimising potential adverse outcomes.
Testing Your Iodine Status
Because thyroid blood tests cannot reliably detect whole-body iodine deficiency, urinary iodine testing is the recommended method for assessing iodine status. Urinary iodide concentration reflects recent dietary iodine intake and provides a clinically meaningful measure of sufficiency.
For a comprehensive assessment that includes both thyroid function markers and iodine status, the Elite Thyroid Profile provides a detailed evaluation of thyroid health alongside key markers relevant to iodine metabolism — helping to identify whether thyroid symptoms may be driven by iodine insufficiency rather than intrinsic thyroid disease.
Frequently Asked Questions About Iodine and Extrathyroidal Health
Can I be iodine-deficient even if my thyroid blood tests are normal?
Yes. The thyroid receives a disproportionately high share of available dietary iodine under conditions of deficiency, meaning thyroid hormone levels can remain within the normal range even when extrathyroidal tissues — including the breasts, ovaries, and brain — are significantly depleted. Urinary iodine testing is the only reliable way to assess whole-body iodine status.
How does iodine deficiency affect fertility?
Iodine deficiency is associated with anovulatory cycles, reduced likelihood of conception, and increased risk of miscarriage and recurrent pregnancy loss. Women with low urinary iodine concentrations have been shown to be 46% less likely to achieve pregnancy per menstrual cycle compared to women with adequate iodine levels.
Is iodine important during pregnancy?
Yes — iodine is critical during pregnancy for fetal thyroid hormone production, brain myelination, and neurocognitive development. Deficiency during the first trimester is associated with reduced IQ, neurological damage, and congenital hypothyroidism. Supplementation should ideally begin before conception.
What is the difference between iodide and molecular iodine?
Iodide (I⁻) is the form primarily used by the thyroid to produce thyroid hormones. Molecular iodine (I₂) is preferentially used by extrathyroidal tissues, where it acts as an antioxidant, immune modulator, and cell differentiator. Both forms have distinct and complementary roles in supporting whole-body health.
Can iodine support breast health?
Research suggests that iodine — particularly molecular iodine — plays a protective role in breast tissue. It has been shown to suppress breast cancer cell growth, reduce tumour size in animal models, and improve oestrogen metabolism via pathways that have antiproliferative effects. Iodine deficiency has been associated with fibrocystic breast disease and an increased risk of breast cancer.
How much iodine do I need each day?
The current RDA of 150 mcg per day was established to prevent goitre and may be insufficient to support extrathyroidal tissues. Based on dietary analysis of Japanese populations, an intake of 1 to 3 mg per day has been proposed as a more comprehensive target. However, iodine dosing should be individualised and guided by testing and clinical assessment, particularly for those with existing thyroid conditions.
Conclusion
Iodine is far more than a thyroid mineral. Its roles in breast health, ovarian function, fertility, endometrial integrity, and fetal neurocognitive development make it one of the most clinically significant micronutrients in the body. Yet iodine deficiency remains widespread and is routinely missed by standard thyroid blood tests.
Understanding your iodine status through targeted urinary testing — and addressing deficiency with appropriate supplementation and dietary support — is an important step towards optimising hormonal health, reproductive outcomes, and long-term wellbeing.
Originally written by ZRT Laboratory author. Reproduced with permission. Last reviewed: May 2026.